For citations:
Stukan A.I., Khachmamuk Z.K., Antipova V.V., Dzagashtokova A.V. Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal BRCA1-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy. Tumors of female reproductive system. 2022;18(3):78-88. (In Russ.) https://doi.org/10.17650/1994-4098-2022-18-3-78-88
Email this article 